Medifast Inc (MED) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Total · absolute moveSwitch to Alpha · NYSE
Medifast Inc (MED) stock forecast summary
On Oct. 14, 2026, MED is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
Medifast Inc is a small-cap company with a market capitalization of $130M.
A per-ticker accuracy statistic for MED is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +4.5%, buy ≥ +3.4%, sell < +2.1%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MED included.
Follow MED freeMED price chart and AI forecast
How MED ranks among 4009 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Medifast Inc (MED) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Miscellaneous Food Preparations & Kindred Products peers listed below that report each metric.
Valuation & Market
| Metric | MED | Rank |
|---|---|---|
| Market Cap | $130M | – |
| P/B Ratio | 0.66x | – |
| Dividend Yield | 0.58% | – |
| EPS | $-2.20 | – |
| Book Value/Share | $17.56 | – |
| Revenue/Share | $28.35 | – |
| FCF/Share | $0.36 | – |
Profitability & Margins
| Metric | MED | Rank |
|---|---|---|
| ROE | -13.0% | – |
| ROA | -9.8% | – |
| ROIC | -8.9% | – |
| Gross Margin | 69.2% | – |
| Operating Margin | -6.2% | – |
| Net Margin | -8.1% | – |
| EBT Margin | -4.4% | – |
| Tax Rate | -83.2% | – |
The effective tax rate is outside the normal band, which points to a large non-recurring tax item in the trailing twelve months; headline net income, net margin and P/E are affected by it.
Financial Health
| Metric | MED | Rank |
|---|---|---|
| Current Ratio | 4.86x | – |
| Quick Ratio | 4.35x | – |
| D/E Ratio | 0.33x | – |
| Financial Leverage | 1.33x | – |
| Interest Coverage | 585.2x | – |
| Working Capital | $160M | – |
Cash Flow
| Metric | MED | Rank |
|---|---|---|
| Operating Cash Flow | $9M | – |
| Free Cash Flow | $4M | – |
| Capital Spending | -$5M | – |
| OCF Growth YoY | 111.7% | – |
| FCF/Sales | 1.3% | – |
| CapEx/Sales | 1.5% | – |
Operational Efficiency
| Metric | MED | Rank |
|---|---|---|
| Asset Turnover | 1.22x | – |
| Inventory Turnover | 4.6x | – |
| Fixed Assets Turnover | 11.3x | – |
| Days Inventory | 79 days | – |
Income Statement
| Metric | MED | Rank |
|---|---|---|
| Total Revenue | $316M | – |
| Operating Income | -$19M | – |
| Net Income | -$25M | – |
| SG&A Expense | $239M | – |
| Cost of Goods Sold | $97M | – |
Dividend & Shareholder Information
| Metric | MED | Rank |
|---|---|---|
| Dividends Per Share | $0.07 | – |
| Shares Outstanding | 11M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $202M | 77.2% of assets |
| Cash & Short-term Investments | $72M | 27.5% of assets |
| Inventory | $21M | 8.1% of assets |
| Total Liabilities | $64M | 24.5% of assets |
MED quarterly financials and insider trading
Medifast Inc (MED) industry peers
Companies classified under the same SEC industry code as Medifast Inc (Miscellaneous Food Preparations & Kindred Products): 4 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere MED sits on the market map
Medifast Inc (MED) stock news
Loading...
Medifast Inc (MED) stock forecast FAQ
What is the Medifast Inc (MED) stock forecast?
On Oct. 14, 2026, MED is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 4009 stocks scored that day.
How accurate are Medifast Inc stock predictions?
A per-ticker accuracy statistic for MED is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Medifast Inc forecasts updated?
Medifast Inc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Medifast Inc's industry peers?
4 issuers in our coverage, MED included, share the SEC industry code Miscellaneous Food Preparations & Kindred Products. The largest are: Mccormick & Co Inc (MKC), Utz Brands, Inc. (UTZ), Coffee Holding Co Inc (JVA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.